Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology

European Journal of Preventive Cardiology

Volumn 24, Issue 13, 2017, Pages 1371-1380

  Pogosova, Nana ^a,b   Kotseva, Kornelia ^a,c,d   De Bacquer, Dirk ^a,d   Von Känel, Roland ^e,f   De Smedt, Delphine ^d   Bruthans, Jan ^a,g,h   Dolzhenko, Maryna ⁱ  

^a European Society of Cardiology   (France)

^b NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d GHENT UNIVERSITY   (Belgium)

^e Clinic Barmelweid   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g CHARLES UNIVERSITY   (Czech Republic)

^h Thomayer's Teaching Hospital   (Czech Republic)

ⁱ SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

Author keywords

Anxiety; cardiovascular risk; coronary artery disease; depression

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANXIETY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE REGISTRY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEDENTARY LIFESTYLE; SOCIAL PSYCHOLOGY; CARDIOLOGY; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; EUROPE; HEALTH SURVEY; MEDICAL SOCIETY; MORBIDITY; PROCEDURES; PROGNOSIS; PSYCHOLOGY; REGISTER; TRENDS;

ADULT; AGED; ANXIETY; CARDIOLOGY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PREVALENCE; PROGNOSIS; REGISTRIES; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 85028304675     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487317711334     Document Type: Article

References (42)

1. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012; 33: 1635-1701.
2. Pogosova N, Saner H, Pedersen SS, et al. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol 2015; 22: 1290-1306.
3. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 953-962.
4. Gan Y, Gong Y, Tong X, et al. Depression and the risk of coronary heart disease: A meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14: 371-371.
5. Rugulies R,. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002; 23: 51-61.
6. Wulsin LR, Singal BM,. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65: 201-210.
7. Nicholson A, Kuper H, Hemingway H,. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
8. Tully PJ, Cosh SM, Baumeister H,. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res 2014; 77: 439-448.
9. Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: A meta-analysis. J Am Coll Cardiol 2010; 56: 38-46.
10. Roest AM, Martens EJ, Denollet J, et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom Med 2010; 72: 563-569.
11. Meijer A, Conradi HJ, Bos EH, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33: 203-216.
12. Nabi H, Shipley MJ, Vahtera J, et al. Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: The Whitehall II cohort study. Heart 2010; 96: 1645-1650.
13. Watkins LL, Koch GG, Sherwood A, et al. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc 2013; 2: e000068-e000068.
14. Carney RM, Freedland KE, Steinmeyer B, et al. Depression and five year survival following acute myocardial infarction: A prospective study. J Affect Disord 2008; 109: 133-138.
15. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160: 1818-1823.
16. Doyle F, Rohde D, Rutkowska A, et al. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990-2013. Psychosom Med 2014; 76: 44-57.
17. DiMatteo MR, Lepper HS, Croghan TW,. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-2107.
18. Gehi A, Haas D, Pipkin S, et al. Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch Intern Med 2005; 165: 2508-2513.
19. Rieckmann N, Kronish IM, Haas D, et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006; 152: 922-927.
20. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024-2028.
21. Taylor CB, Conrad A, Wilhelm FH, et al. Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Psychosom Med 2006; 68: 538-546.
22. Shimbo D, Child J, Davidson K, et al. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002; 89: 331-333.
23. Wittstein IS,. Depression, anxiety, and platelet reactivity in patients with coronary heart disease. Eur Heart J 2010; 31: 1573-1582.
24. Austin AW, Wissmann T, von Kanel R,. Stress and hemostasis: An update. Semin Thromb Hemost 2013; 39: 902-912.
25. Severus WE, Littman AB, Stoll AL,. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 2001; 9: 280-293.
26. Cohen HW, Gibson G, Alderman MH,. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000; 108: 2-8.
27. Rothenbacher D, Jaensch A, Mons U, et al. Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need. Eur J Prev Cardiol. 2015; 22: 1129-1138.
28. Leung YW, Flora DB, Gravely S, et al. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: Meta-analysis. Psychosom Med 2012; 74: 786-801.
29. Rutledge T, Redwine LS, Linke SE, et al. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013; 75: 335-349.
30. Pajak A, Jankowski P, Kotseva K, et al. EUROASPIRE Study Group. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: The EUROASPIRE III Study. Eur J PrevCardiol 2013; 20: 331-340.
31. Kotseva K, Wood D, De Bacquer D, et al.; on behalf of the EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J PrevCardiol 2016; 23: 636-648.
32. International Physical Activity Questionnaire (IPAQ). Downloadable questionnaires. Available at: https://sites.google.com/site/theipaq/questionnaire-links (accessed 16 May 2015).
33. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psych Scand 1983; 67: 361-370.
34. World Health Organization. Women's mental health: An evidence based review. Report no.: WHO/MSD/MDP/00.1 2000: 47. Geneva: World Health Organization, 2000.
35. Blanco C, Rubio J, Wall M, et al. Risk factors for anxiety disorders: Common and specific effects in a national sample. Depress Anxiety 2014; 31: 756-764.
36. Ramamurthy G, Trejo E and Faraone SV. Depression treatment in patients with coronary artery disease: A systematic review. Prim Care Companion CNS Disord. Epub ahead of print 24 October 2013. DOI: 10.4088/PCC.13r01509.
37. Nicholson A, Kuper H, Hemingway H,. Depression as an etiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
38. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation 2008; 118: 1768-1775.
39. Huffman JC, Celano CM, Beach SR, et al. Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013; 2013: 695925-695925.
40. Bonnet F, Irving K, Terra JL, et al. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 2005; 178: 339-344.
41. Khosravi M, Sotoudeh G, Majdzadeh R, et al. Healthy and unhealthy dietary patterns are related to depression: A case-control study. Psychiatry Investig 2015; 12: 434-442.
42. Thombs BD, Roseman M, Coyne JC, et al. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One 2013; 8: e52654-e52654.